TITLE

DEPRESSIVE SYMPTOMS, NEGATIVE LIFE EVENTS AND INCIDENCE OF LIFETIME TREATMENT OF CANCER IN THE HUNGARIAN POPULATION

AUTHOR(S)
Degi, Csaba L.; Balog, Piroska; Kopp, Maria; Kállay, Éva; Thayer, Julian F.; Csikai, Ellen L.
PUB. DATE
March 2010
SOURCE
Journal of Cognitive & Behavioral Psychotherapies;Mar2010, Vol. 10 Issue 1, p39
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cancer incidence and mortality rates in Hungary are the highest in the Central-Eastern European region. Our investigative study examined associations of cancer-prone behavioral risk factors, psychosocial variables and demographic characteristics with cancer treatment on a population level. Data were obtained from the Hungarostudy 2002, a cross-sectional, representative survey of the adult Hungarian population (n=12643). Controlling for all other study variables in a binary logistic regression model, results revealed that the odds of having been treated for cancer were almost twice as high among persons with depression and respondents who experienced negative life events than for those who were not depressed and reported no negative life events. These results send a warning signal to the Hungarian health care system regarding the widespread need for education, prevention, psycho-social screening programs and treatment of depression.
ACCESSION #
60820809

 

Related Articles

  • Metformin and Breast Cancer: Molecular Targets. Faria, J.; Negalha, G.; Azevedo, A.; Martel, F. // Journal of Mammary Gland Biology & Neoplasia;Jun2019, Vol. 24 Issue 2, p111 

    Metformin has been the first-line drug for the treatment of type II diabetes mellitus for decades, being presently the most widely prescribed antihyperglycemic drug. Retrospective studies associate the use of metformin with a reduction in cancer incidence and cancer-related death. However,...

  • Metformin reduces cancer risk.  // Pulse;4/30/2005, Vol. 65 Issue 17, p18 

    The article cites a study which states that metformin may substantially reduce the risk of cancer. A study of 12,000 people with type 2 diabetes, published online in the "British Medical Journal" this week, found that cancer rates were reduced by 23 percent in users of the drug. The researchers...

  • Risk of skin cancer after neonatal phototherapy: retrospective cohort study. David H Brewster // Archives of Disease in Childhood;Oct2010, Vol. 95 Issue 10, p826 

    OBJECTIVE: To assess the risk of skin cancer in persons treated with neonatal phototherapy (NNPT) for jaundice. DESIGN: Retrospective cohort study. SETTING: Grampian Region, Scotland, UK. DATA SOURCE: Aberdeen Maternity and Neonatal Databank. NNPT exposure was abstracted from paper records...

  • NUTRI- COGNOSY IN CANCER. SASIKALA SASIKUMAR; KANNAN EAGAPPAN // International Journal of Pharmacy & Pharmaceutical Sciences;2014, Vol. 6 Issue 3, p23 

    Cancer is a hyper proliferative disorder that is usually treated by chemotherapeutic agents that are toxic not only to tumour cells but also to normal cells, so these agents produce major side effects. And also, these agents are highly expensive and thus not affordable by most. Traditional...

  • Knowledge is key in cancer care.  // Marketing Health Services;Summer2002, Vol. 22 Issue 2, p6 

    The article announces that the Intercultural Cancer Council (ICC) feels that the survival rates of cancer patients who lack adequate access to quality cancer treatment would improve significantly if those patients kept up to date on current prevention and treatment research. An increase in the...

  • Bisphosphonate use associated with decreased risk for breast cancer.  // Endocrine Today;Apr2010, Vol. 8 Issue 4, p24 

    The article discusses research by P. A. Newcomb which found that risk of breast cancer is reduced by long-term use of biphosphonates.

  • Age Plays Too Big a Role in Prostate Cancer Treatment Decisions.  // International Journal of Cancer Research;2011, Vol. 7 Issue 2, p152 

    No abstract available.

  • Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected. Hyuna Sung; Rosenberg, Philip S.; Wan-Qing Chen; Hartman, Mikael; Wei-yen Lim; Kee Seng Chia; Oscar Wai-Kong Mang; Chun-Ju Chiang; Daehee Kang; Roger Kai-Cheong Ngan; Lap Ah Tse; Anderson, William F.; Xiaohong R. Yang // JNCI: Journal of the National Cancer Institute;7/15/2015, Vol. 107 Issue 7, p1 

    Background: Previous reports suggested that female breast cancer is associated with earlier ages at onset among Asian than Western populations. However, most studies utilized cross-sectional analyses that may be confounded by calendar-period and/or birth cohort effects. We, therefore, considered...

  • Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer in a tertiary institution in Lagos, Nigeria. Ibrahim, Nasiru A.; Odusanya, Olumuyiwa O. // BMC Cancer;2009, Vol. 9, Special section p1 

    Background: Breast cancer is the leading female malignancy in Nigeria. Screening for early detection has led to reduction in mortality from the disease. It is known that attitudes of physicians and motivation by community nurses influence uptake of screening methods by women. This study aims to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics